Bell Investment Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-87
Closed -$3.67K 2016
2023
Q2
$3.67K Buy
87
+27
+45% +$1.09K ﹤0.01% 982
2023
Q1
$2.14K Hold
60
﹤0.01% 1231
2022
Q4
$2.2K Buy
60
+50
+500% +$1.98K ﹤0.01% 1235
2022
Q3
$0 Sell
10
-21
-68% -$1.36K ﹤0.01% 2021
2022
Q2
$2K Buy
+31
New +$2.27K ﹤0.01% 1279
2021
Q4
$1K Hold
5
﹤0.01% 1703
2021
Q3
$0 Buy
+5
New +$453 ﹤0.01% 1856

Other funds holding SYNH

Bell Investment Advisors's SYNH Position: Q3 2023 in Review

Bell Investment Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 87 shares — an estimated $3.67K sold.

Bell Investment Advisors first reported a position in SYNH in Q3 2021 and held it in 7 quarters. The position peaked at $3.67K in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Bell Investment Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Bell Investment Advisors sold 87 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $3.67K.
  • Bell Investment Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2021 and held it in 7 quarters.
  • Bell Investment Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $3.67K in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Bell Investment Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.